TFPI2 and Miyoshi myopathy: In summary, we showed in this study that MM can be stratified into at least two subgroups based on promoter methylation status, that high‐methylation subgroup exhibits advanced tumor phenotypes, characterized by thicker progression and worse prognosis, and that methylation of TFPI2 contributes to such progressive phenotype of MM.